Tg Therapeutics (TGTX) FCF Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly FCF Margin of 8.76% for Q1 2026, up 1502.0% year-over-year from 0.55% in Q1 2025, and down 186.07% quarter-over-quarter from 10.17% in Q4 2025.
Tg Therapeutics (TGTX) FCF Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' FCF Margin history runs 10 years deep, the most recent figure standing at 8.76% for Q1 2026.
- In Q1 2026, FCF Margin rose 1502.0% year-over-year to 8.76%; the TTM figure through Mar 2026 stood at 2.03% (up 1379.0% YoY), while the FY2025 annual figure was 4.05%, up 827.0% from the prior year.
- FCF Margin for Q1 2026 stood at 8.76%, down from 10.17% in the prior quarter.
- The five-year high for FCF Margin was 50.48% in Q3 2023, with the low at 36701.06% in Q3 2022.
- The 5-year median for FCF Margin is 23.72% (2024), against an average of 4664.84%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin slumped 3338678 bps in 2022, then jumped 3675154 bps in 2023.
- Tg Therapeutics' FCF Margin stood at 29841.25% in 2022, then surged by 100 bps to 30.04% in 2023, then increased by 21 bps to 23.72% in 2024, then soared by 143 bps to 10.17% in 2025, then plunged by 186 bps to 8.76% in 2026.
- Business Quant data shows TGTX's FCF Margin at 8.76% in Q1 2026, 10.17% in Q4 2025, and 14.37% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 16.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.21% |
| Mar 31, 2026 | -8.76% |
| Dec 31, 2025 | 10.17% |
| Sep 30, 2025 | -14.37% |
| Jun 30, 2025 | 5.24% |
| Mar 31, 2025 | -23.78% |
| Dec 31, 2024 | -23.72% |
| Sep 30, 2024 | -14.58% |
| Jun 30, 2024 | 7.54% |
| Mar 31, 2024 | -12.93% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | 50.48% |
| Jun 30, 2023 | -261.32% |
| Mar 31, 2023 | -767.68% |
| Dec 31, 2022 | -29,841.25% |
| Sep 30, 2022 | -36,701.06% |
| Jun 30, 2022 | -8,268.69% |
| Mar 31, 2022 | -3,407.54% |
| Dec 31, 2021 | -3,747.91% |
| Sep 30, 2021 | -3,314.29% |